All In Biotech

Free tool

FAERS Monitor: Fyarro

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 213312 or its brand name (Fyarro, Sirolimus). Reports on generic versions are filed under their own applications.

Reports

13,519

Serious

11,687

86% of reports

Hospitalization

4,682

Death reported

2,180

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use2,076
  • drug ineffective1,140
  • product use in unapproved indication786
  • pyrexia533
  • diarrhoea529
  • pneumonia500
  • drug interaction450
  • acute kidney injury444
  • thrombotic microangiopathy386
  • transplant rejection384
  • cytomegalovirus infection355
  • condition aggravated318
  • nausea318
  • toxicity to various agents316
  • death315

Reports by year received

View as table
YearReports
200441
200553
200651
2007232
2008194
2009294
2010152
2011253
2012231
2013204
2014239
2015315
2016425
2017598
2018845
2019990
20201,021
20211,054
20221,240
20231,139
20241,444
20251,502
20261,002

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,640 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
transplant rejectionSignal38478.270.727,819
thrombotic microangiopathySignal38664.158.022,986
cytomegalovirus infectionSignal35533.930.611,081
product use in unapproved indicationSignal7864.94.62,493
acute kidney injurySignal4444.54.11,221
drug interactionSignal4504.44.01,194
off label useSignal2,0763.73.64,245
toxicity to various agentsSignal3162.92.6399
pneumoniaSignal5002.42.2415
pyrexiaSignal5332.42.2440
condition aggravated3181.61.577
drug ineffective1,1401.31.3108
diarrhoea5291.31.232
nausea3180.60.674
death3150.60.5107

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.